How much does Trametinib cost?

Trametinib (Trametinib) produced by the pharmaceutical company Novartis and sold under the trade name Megenin, is used to treat cancer cells in adults with a specific genetic mutation (change) in their genes, called "BRAF V600." Trametinib is mainly used to treat melanoma (a type of skin cancer) that has spread or cannot be removed by surgery, advanced (stage III) melanoma after surgery, and advanced non-small cell lung cancer. Trametinib contains the effective substance Trametinib, which can be combined with dabrafenib (dabrafenib) to treat the disease, or can be treated with a single drug. It is a prescription drug and needs to be used under the guidance and supervision of a doctor. The recommended dose for adult patients is 2 mg of tablets, taken orally once a day.

The original drug Trametinib has been launched in China and has entered the scope of Class B medical insurance, but it may only be purchased by patients who meet the indications of Trametinib, such as BRAF V600 mutation-positive unresectable or metastatic melanoma, etc. The price of each box of 2mg*30 tablets is around RMB 10,000-20,000. Different regions have different reimbursement ratios and prices, which are expensive. The price of the Turkish version of the original drug Trametinib listed overseas is around RMB 7,900 per box of 2 mg*30 tablets (the price may fluctuate due to the exchange rate). Generic trametinib is also produced in other countries. The price of the 2 mg*30 tablet per box produced by the Lao pharmaceutical factory is around RMB 2,950 (the price may fluctuate due to the exchange rate). The ingredients and efficacy of foreign generic drugs are basically the same as those of domestic and foreign original drugs.